These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12163588)

  • 21. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
    Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
    J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravirion cohesion of matrix protein M1 with ribonucleocapsid is a prerequisite of influenza virus infectivity.
    Zhirnov OP; Manykin AA; Rossman JS; Klenk HD
    Virology; 2016 May; 492():187-96. PubMed ID: 26954078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells.
    Zhirnov O; Klenk HD
    Virology; 2003 Aug; 313(1):198-212. PubMed ID: 12951033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.
    Magnen M; Gueugnon F; Guillon A; Baranek T; Thibault VC; Petit-Courty A; de Veer SJ; Harris J; Humbles AA; Si-Tahar M; Courty Y
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28615200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemagglutinin-Neuraminidase Balance Influences the Virulence Phenotype of a Recombinant H5N3 Influenza A Virus Possessing a Polybasic HA0 Cleavage Site.
    Diederich S; Berhane Y; Embury-Hyatt C; Hisanaga T; Handel K; Cottam-Birt C; Ranadheera C; Kobasa D; Pasick J
    J Virol; 2015 Nov; 89(21):10724-34. PubMed ID: 26246579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.
    Alvarado-Facundo E; Gao Y; Ribas-Aparicio RM; Jiménez-Alberto A; Weiss CD; Wang W
    J Virol; 2015 Feb; 89(4):1975-85. PubMed ID: 25473053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
    Hayashi H; Kubo Y; Izumida M; Takahashi E; Kido H; Sato K; Yamaya M; Nishimura H; Nakayama K; Matsuyama T
    Front Cell Infect Microbiol; 2018; 8():91. PubMed ID: 29629340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
    Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
    J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids.
    Endo Y; Carroll KN; Ikizler MR; Wright PF
    J Virol; 1996 Mar; 70(3):2055-8. PubMed ID: 8627736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aprotinin and similar protease inhibitors as drugs against influenza.
    Zhirnov OP; Klenk HD; Wright PF
    Antiviral Res; 2011 Oct; 92(1):27-36. PubMed ID: 21802447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza A virus hemagglutinin containing basolateral localization signal does not alter the apical budding of a recombinant influenza A virus in polarized MDCK cells.
    Barman S; Adhikary L; Kawaoka Y; Nayak DP
    Virology; 2003 Jan; 305(1):138-52. PubMed ID: 12504548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage.
    Wang W; Suguitan AL; Zengel J; Chen Z; Jin H
    Vaccine; 2012 Jan; 30(5):872-8. PubMed ID: 22172510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation at hemagglutinin Asn-167 protects the H6N1 avian influenza virus from tryptic cleavage at Arg-201 and maintains the viral infectivity.
    He JL; Chiu YC; Chang SC; Wang CH; Juang RH
    Virus Res; 2015 Feb; 197():101-7. PubMed ID: 25527464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bacterial microflora of the lower digestive tract of free-range waterfowl on influenza virus activation.
    King MD; Guentzel MN; Arulanandam BP; Bodour AA; Brahmakshatriya V; Lupiani B; Chambers JP
    Appl Environ Microbiol; 2011 Jun; 77(12):4119-25. PubMed ID: 21531837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic activation of the 1918 influenza virus hemagglutinin.
    Chaipan C; Kobasa D; Bertram S; Glowacka I; Steffen I; Tsegaye TS; Takeda M; Bugge TH; Kim S; Park Y; Marzi A; Pöhlmann S
    J Virol; 2009 Apr; 83(7):3200-11. PubMed ID: 19158246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cleavage of influenza virus hemagglutinin as affected by serum plasmin in cell culture and in vivo].
    Zhirnov OP; Ovcharenko AV; Bukrinskaia AG
    Vopr Virusol; 1981; (6):677-87. PubMed ID: 6461136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological properties of H5 hemagglutinin expressed by vaccinia virus vector and its immunological reactivity with human sera.
    Noisumdaeng P; Pooruk P; Kongchanagul A; Assanasen S; Kitphati R; Auewarakul P; Puthavathana P
    Viral Immunol; 2013 Feb; 26(1):49-59. PubMed ID: 23374152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
    Böttcher-Friebertshäuser E; Lu Y; Meyer D; Sielaff F; Steinmetzer T; Klenk HD; Garten W
    Vaccine; 2012 Dec; 30(51):7374-80. PubMed ID: 23072892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
    Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
    J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
    Okumura Y; Takahashi E; Yano M; Ohuchi M; Daidoji T; Nakaya T; Böttcher E; Garten W; Klenk HD; Kido H
    J Virol; 2010 May; 84(10):5089-96. PubMed ID: 20219906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.